ANIP
ANI Pharmaceuticals, Inc.Healthcare$74.21
▼ Bearish
Mkt Cap: $1.67B|Float: 19.0M|SI: 19.0%|DTC: 9.7
Data as of market close Apr 2, 2026
IV Rank
51
IV Pctl
44%
HV 20d
3509.0%
52W Range
$57-$100
ATR(14)
$2.25
Exp. Move
±7.5%
P/C Ratio
1.67
Earnings
May 8
GEX Negative
DEX Long
Net Put Premium
IV Moderate
Max Pain Above
Exp. Move Wide
High Put/Call
ANIP Key Options Data
- IV Rank
- 50.8%
- Total GEX
- $-0.00B
- Total DEX
- $0.3M
- Max Pain
- $80.00
- Expected Move
- ±7.5%
- Put/Call OI
- 1.67
- Net Premium
- $-0.2M
- Spot Price
- $74.21
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.60 | ±7.5% | $68.61 | $79.81 |
| 2026-07-17 | 106 | ±$14.60 | ±19.7% | $59.61 | $88.81 |
| 2026-10-16 | 197 | ±$13.05 | ±17.6% | $61.16 | $87.26 |
Explore ANIP options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.